person

Jorge G. G.

Country
Spain
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
182
Sites with multiple studies

Has run more than one trial at 182 of 401 partner sites.

Specializations

Lung Cancer Research

The investigator specializes in treating non-small cell lung cancer (NSCLC), with particular emphasis on advanced and metastatic disease states. Their research encompasses various therapeutic approaches for ROS1-positive NSCLC and cases involving KRAS G12C mutations.

  • Advanced/Metastatic NSCLC Treatment
  • Brain Metastasis Management
  • Targeted Molecular Therapies

Additional focus includes small cell lung cancer (SCLC) treatment strategies, particularly in extensive-stage disease.

Immunotherapy Applications

The investigator explores innovative immunotherapy combinations in cancer treatment, including work with pembrolizumab and novel immune checkpoint inhibitors. Their research includes evaluation of biosimilar therapeutics and combination approaches with conventional treatments.

  • Checkpoint Inhibitor Therapy
  • Combination Immunotherapy
  • Novel Immunologic Agents

Research extends to antibody-drug conjugates and their integration with immunotherapy protocols.

Solid Tumor Therapeutics

The investigator conducts research on advanced solid tumors, including studies of novel therapeutic compounds and combination strategies. Their work encompasses head and neck cancers, with particular attention to squamous cell carcinomas.

  • Novel Therapeutic Compounds
  • Combination Treatment Strategies
  • Personalized Medicine Approaches

Focus includes evaluation of individualized gene therapy approaches in advanced cancers.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.